Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5–11 years of age in Brazil: A prospective test-negative design study
-
Published:2024-10
Issue:
Volume:269
Page:106903
-
ISSN:0165-2478
-
Container-title:Immunology Letters
-
language:en
-
Short-container-title:Immunology Letters
Author:
Rodrigues Cristina de OliveiraORCID, Spinardi Julia, Rosa Regis GoulartORCID, Falavigna Maicon, de Souza Emanuel MaltempiORCID, Manfio Josélia Larger, de Souza Ana PaulaORCID, de Araujo Cintia Laura Pereira, Cohen Mírian, Barbosa Gynara Rezende Gonzalez do Valle, Silva Fernanda Kelly RomeiroORCID, Sganzerla DanielORCID, da Silva Mariana Motta Dias, Ferreira DiogoORCID, Kunkel Nicolas TacianoORCID, Camargo Nathan IoriORCID, Sarturi Jean Carlos, Guilhem Márcia Cristina, de Oliveira Jaqueline Carvalho, Lopes Caroline Cardoso, Widmar Fernanda, Barufi Letícia Killes, da Silva Gabrielle Nunes, Gradia Daniela FioriORCID, Brandalize Ana Paula Carneiro, Royer Carla AdrianeORCID, Luiz Rafael Messias, Baura Valter Antonio, Abreu HellenORCID, Poitevin Carolina GraciaORCID, Kucharski Gabriela Almeida, Pedrotti Fernando, Valluri Srinivas Rao, Srivastava Amit, Julião Viviane Wal, Melone Olga Chameh, Allen Kristen E., Kyaw Moe H, Castillo Graciela del Carmen MoralesORCID, McLaughlin John M
Funder
Hospital Moinhos de Vento Pfizer Inc
|
|